Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
16.04
-0.33 (-2.02%)
At close: Apr 28, 2026, 4:00 PM EDT
16.04
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Aurinia Pharmaceuticals Market Cap
Aurinia Pharmaceuticals has a market cap or net worth of $2.08 billion as of April 28, 2026. Its market cap has increased by 106.75% in one year.
Market Cap
2.08B
Enterprise Value
1.77B
1-Year Change
106.75%
Ranking
Category
Stock Price
$16.04
Market Cap Chart
Since September 3, 2014, Aurinia Pharmaceuticals's market cap has increased from $125.50M to $2.08B, an increase of 1,560.73%. That is a compound annual growth rate of 27.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 2.18B | 3.51% |
| Dec 31, 2025 | 2.10B | 63.56% |
| Dec 31, 2024 | 1.29B | -0.41% |
| Dec 29, 2023 | 1.29B | 110.29% |
| Dec 30, 2022 | 613.90M | -79.30% |
| Dec 31, 2021 | 2.97B | 69.58% |
| Dec 31, 2020 | 1.75B | -8.45% |
| Dec 31, 2019 | 1.91B | 233.25% |
| Dec 31, 2018 | 573.20M | 50.68% |
| Dec 29, 2017 | 380.40M | 366.75% |
| Dec 30, 2016 | 81.50M | 3.69% |
| Dec 31, 2015 | 78.60M | -31.17% |
| Dec 31, 2014 | 114.20M | -9.00% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Definium Therapeutics | 2.24B |
| Tyra Biosciences | 2.24B |
| Ascentage Pharma Group International | 2.20B |
| Adaptive Biotechnologies | 2.18B |
| Sarepta Therapeutics | 2.13B |
| Zymeworks | 2.07B |
| Ocular Therapeutix | 2.07B |
| Capricor Therapeutics | 2.04B |